![](/img/cover-not-exists.png)
P-284Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): “first-in-cancer” phase Ib study
Van Cutsem, E, Shitara, K, Deng, W, Vaury, A, Tseng, L, Wang, X, Millholland, J, Shilkrut, M, Mookerjee, B, Jonasch, EVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz155.283
Date:
July, 2019
File:
PDF, 105 KB
2019